BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26889774)

  • 1. Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and Development.
    Cheng Y; El-Kattan A; Zhang Y; Ray AS; Lai Y
    Chem Res Toxicol; 2016 Apr; 29(4):545-63. PubMed ID: 26889774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to Reduce Solute Carrier-Mediated Toxicity.
    Hu S; Sprowl JA
    Clin Pharmacol Ther; 2018 Nov; 104(5):799-802. PubMed ID: 30028006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
    Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
    Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics and systems biology of membrane transporters.
    Yan Q
    Mol Biotechnol; 2005 Jan; 29(1):75-88. PubMed ID: 15668521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions.
    Zolk O; Fromm MF
    Clin Pharmacol Ther; 2011 Jun; 89(6):798-805. PubMed ID: 21471963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions.
    Chu X; Chan GH; Evers R
    J Pharm Sci; 2017 Sep; 106(9):2357-2367. PubMed ID: 28416420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
    Evers R; Piquette-Miller M; Polli JW; Russel FGM; Sprowl JA; Tohyama K; Ware JA; de Wildt SN; Xie W; Brouwer KLR;
    Clin Pharmacol Ther; 2018 Nov; 104(5):900-915. PubMed ID: 29756222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.
    Koo SH; Lo YL; Yee JY; Lee EJ
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1821-37. PubMed ID: 26489003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Drug Transporters on Pharmacological Responses and Safety.
    Liu CX; Yi XL; Fan HR; Wu WD; Zhang X; Xiao XF; He X
    Curr Drug Metab; 2015; 16(9):732-52. PubMed ID: 26630905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease, drug metabolism, and transporter interactions.
    Staudinger JL
    Pharm Res; 2013 Sep; 30(9):2171-3. PubMed ID: 23868338
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?
    McLean C; Wilson A; Kim RB
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S40-58. PubMed ID: 27385178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel, 384-well high-throughput assay panels for human drug transporters: drug interaction and safety assessment in support of discovery research.
    Tang H; Shen DR; Han YH; Kong Y; Balimane P; Marino A; Gao M; Wu S; Xie D; Soars MG; O'Connell JC; Rodrigues AD; Zhang L; Cvijic ME
    J Biomol Screen; 2013 Oct; 18(9):1072-83. PubMed ID: 24062352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporter-mediated tissue targeting of therapeutic molecules in drug discovery.
    Zhou J; Xu J; Huang Z; Wang M
    Bioorg Med Chem Lett; 2015 Mar; 25(5):993-7. PubMed ID: 25650254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of Renal Drug Transporter in Drug Disposition and Renal Toxicity.
    Yang X; Han L
    Adv Exp Med Biol; 2019; 1141():341-360. PubMed ID: 31571169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hepatic transporters in drug elimination.
    Funk C
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):363-79. PubMed ID: 18433342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond drug-drug interactions: effects of transporter inhibition on endobiotics, nutrients and toxins.
    Lepist EI; Ray AS
    Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1075-1087. PubMed ID: 28847160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-protein interactions of drug uptake transporters that are important for liver and kidney.
    Zhang Y; Hagenbuch B
    Biochem Pharmacol; 2019 Oct; 168():384-391. PubMed ID: 31381872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug trafficking: recent advances in therapeutics and disease.
    Sprowl JA; Sparreboom A
    Clin Pharmacol Ther; 2012 Nov; 92(5):531-4. PubMed ID: 23085872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactions.
    Lu C; Liao M; Cohen L; Xia CQ
    Curr Drug Discov Technol; 2010 Sep; 7(3):199-222. PubMed ID: 20843292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane transporters in drug development.
    Keogh JP
    Adv Pharmacol; 2012; 63():1-42. PubMed ID: 22776638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.